Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort

BACKGROUND: Alzheimer’s disease (AD) is a complex neurodegenerative disorder with β-amyloid pathology as a key underlying process. The relevance of cerebrospinal fluid (CSF) and brain imaging biomarkers is validated in clinical practice for early diagnosis. Yet, their cost and perceived invasiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirtz, Christophe, Busto, Germain U., Bennys, Karim, Kindermans, Jana, Navucet, Sophie, Tiers, Laurent, Lista, Simone, Vialaret, Jérôme, Gutierrez, Laure-Anne, Dauvilliers, Yves, Berr, Claudine, Lehmann, Sylvain, Gabelle, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938625/
https://www.ncbi.nlm.nih.gov/pubmed/36800984
http://dx.doi.org/10.1186/s13195-023-01188-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938625/
https://www.ncbi.nlm.nih.gov/pubmed/36800984
http://dx.doi.org/10.1186/s13195-023-01188-8

Ejemplares similares